Neon Therapeutics, Inc.

CAMBRIDGE, MA How do I update this listing?

Create Email Alert

Neon Therapeutics is based out of Cambridge. Neon Therapeutics, Inc. operates as a biotechnology company. The Company offers a neoantigen platform to develop neoantigen-targeted therapies for the treatment of cancer by directing the immune system. Neon Therapeutics offers its services in the United States. The firm last filed a Form D notice of exempt offering of securities on 2017-12-13. The notice included securities offered of Equity

Contact Info

neon therapeutics, inc.
40 ERIE STREET
CAMBRIDGE MA    02139

Business Phone: 617-337-4701
SEC SIC CODE:
2836-BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

Active Schedule 13D and 13G events

Sign in to see

Insider Transactions in the past year

Loading...

Form D Filings

Form D is a form to be used to file a notice of an exempt offering of securities with the Securities and Exchange Commission. Form D contains basic information about the offering and the company.

Form D Filings
Filing Date Form Type Industry Group Securities Offered Total Offering Amount Total Amount Sold Total Remaining
2017-12-13 D/A BIOTECHNOLOGY Equity 106,000,001 105,999,996 5
2017-01-11 D OTHER HEALTH CARE Equity 70,000,000 69,999,995 5
Other Issuers in Filings
Name Address
No Other Issuers
Related Parties included in filings
Name Address Relationship
HUGH DOWD subscription required
    EXECUTIVE OFFICER DIRECTOR
RICHARD GAYNOR, M.D. subscription required
    EXECUTIVE OFFICER
ROBERT ANG, M.D. subscription required
    EXECUTIVE OFFICER
DANIELLA BECKMAN subscription required
    EXECUTIVE OFFICER
ROBERT TEPPER subscription required
    DIRECTOR
ERIC LANDER subscription required
    DIRECTOR
ROBERT KAMEN subscription required
    DIRECTOR
STEPHEN SHERWIN subscription required
    DIRECTOR
CARY PFEFFER, M.D. subscription required
    DIRECTOR
YASIR AL-WAKEEL subscription required
    EXECUTIVE OFFICER

Elevate your investments